These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37333490)

  • 1. Nanoliposomal VEGF-R2 peptide vaccine acts as an effective therapeutic vaccine in a murine B16F10 model of melanoma.
    Zahedipour F; Zamani P; Mashreghi M; Astaneh M; Sankian M; Amiri A; Jamialahmadi K; Jaafari MR
    Cancer Nanotechnol; 2023; 14(1):62. PubMed ID: 37333490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoliposomal vaccine containing long multi-epitope peptide E75-AE36 pulsed PADRE-induced effective immune response in mice TUBO model of breast cancer.
    Zamani P; Teymouri M; Nikpoor AR; Navashenaq JG; Gholizadeh Z; Darban SA; Jaafari MR
    Eur J Cancer; 2020 Apr; 129():80-96. PubMed ID: 32145473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses.
    Brentville VA; Metheringham RL; Daniels I; Atabani S; Symonds P; Cook KW; Vankemmelbeke M; Choudhury R; Vaghela P; Gijon M; Meiners G; Krebber WJ; Melief CJM; Durrant LG
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32561639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term generation of antiPCSK9 antibody using a nanoliposome-based vaccine delivery system.
    Momtazi-Borojeni AA; Jaafari MR; Badiee A; Sahebkar A
    Atherosclerosis; 2019 Apr; 283():69-78. PubMed ID: 30797988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoliposomal Encapsulation Enhances
    Hatamipour M; Jaafari MR; Momtazi-Borojeni AA; Ramezani M; Sahebkar A
    Anticancer Agents Med Chem; 2019; 19(13):1618-1626. PubMed ID: 31284876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice.
    Zhao Y; Wang H; Yang Y; Jia W; Su T; Che Y; Feng Y; Yuan X; Wang X
    Int J Nanomedicine; 2020; 15():9571-9586. PubMed ID: 33293808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly (I:C)-DOTAP cationic nanoliposome containing multi-epitope HER2-derived peptide promotes vaccine-elicited anti-tumor immunity in a murine model.
    Alipour Talesh G; Ebrahimi Z; Badiee A; Mansourian M; Attar H; Arabi L; Jalali SA; Jaafari MR
    Immunol Lett; 2016 Aug; 176():57-64. PubMed ID: 27260485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of patients with melanoma peptide vaccines: immunologic assessment using the ELISPOT assay.
    Pass HA; Schwarz SL; Wunderlich JR; Rosenberg SA
    Cancer J Sci Am; 1998; 4(5):316-23. PubMed ID: 9815296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
    Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
    Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with dendritic cells pulsed ex vivo with gp100 peptide-decorated liposomes enhances the efficacy of anti PD-1 therapy in a mouse model of melanoma.
    Yazdani M; Gholizadeh Z; Nikpoor AR; Hatamipour M; Alani B; Nikzad H; Mohamadian Roshan N; Verdi J; Jaafari MR; Noureddini M; Badiee A
    Vaccine; 2020 Jul; 38(35):5665-5677. PubMed ID: 32653275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of Tumor-Specific Immunity by p5 HER-2/neu Generated Peptide Encapsulated in Nano-liposomes with High Phase Transition Temperature Phospholipids.
    Yazdani M; Jalali SA; Badiee A; Shariat S; Mansourian M; Arabi L; Abbasi A; Saberi Z; Jaafari MR
    Curr Drug Deliv; 2017; 14(4):492-502. PubMed ID: 27411392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective tumor immunity to melanoma mediated by B16F10 cancer stem cell vaccine.
    Zhao F; Zhang R; Wang J; Wu D; Pan M; Li M; Guo M; Dou J
    Int Immunopharmacol; 2017 Nov; 52():238-244. PubMed ID: 28950176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide vaccination directed against IDO1-expressing immune cells elicits CD8
    Dey S; Sutanto-Ward E; Kopp KL; DuHadaway J; Mondal A; Ghaban D; Lecoq I; Zocca MB; Merlo LMF; Mandik-Nayak L; Andersen MH; Pedersen AW; Muller AJ
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32690770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoliposomes carrying HER2/neu-derived peptide AE36 with CpG-ODN exhibit therapeutic and prophylactic activities in a mice TUBO model of breast cancer.
    Barati N; Nikpoor AR; Razazan A; Mosaffa F; Badiee A; Arab A; Gholizadeh Z; Behravan J; Jaafari MR
    Immunol Lett; 2017 Oct; 190():108-117. PubMed ID: 28736158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity Evaluation of an Experimental Designed Nanoliposomal Vaccine Containing FMDV Immunodominant Peptides.
    Heshmati L; Rezayat SM; Madani R; Emami T; Jafari MR; Golchinfar F; Kazemi M; Azimi Dezfouli SM
    Arch Razi Inst; 2021 Nov; 76(5):1183-1190. PubMed ID: 35355777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer.
    Farzad N; Barati N; Momtazi-Borojeni AA; Yazdani M; Arab A; Razazan A; Shariat S; Mansourian M; Abbasi A; Saberi Z; Badiee A; Jalali SA; Jaafari MR
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):665-673. PubMed ID: 30829072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusion of the dendritic cell-targeting chemokine MIP3α to melanoma antigen Gp100 in a therapeutic DNA vaccine significantly enhances immunogenicity and survival in a mouse melanoma model.
    Gordy JT; Luo K; Zhang H; Biragyn A; Markham RB
    J Immunother Cancer; 2016; 4():96. PubMed ID: 28018602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CD4+ T lymphocytes recognize a vascular endothelial growth factor receptor-2-derived epitope in association with HLA-DR.
    Sun Y; Song M; Jäger E; Schwer C; Stevanovic S; Flindt S; Karbach J; Nguyen XD; Schadendorf D; Cichutek K
    Clin Cancer Res; 2008 Jul; 14(13):4306-15. PubMed ID: 18594014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
    Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
    Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broadening CD4
    Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.